NL-OMON39910已完成4 期
Towards dose optimisation through pharcokinetic profiling of piperacillin/tazobactam in critically ill patients - Pharmocokinetic profiling of piperacillin/tazobactam in the critically ill
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Adult >= 18 yrs
- •Admiited to the ICU
- •Proven or suspected infection
- •Indication for treatment with Piperacillin-tazobactam
排除标准
- •Severe anemia
- •Contraindication for Piperacillin-tazobactam, including known or suspected allergy
- •Contraindication for continuous infusion
研究者
相似试验
已完成
不适用
Study of blood level of lifesaving antibiotic meropenum in serious ICU patients in relation to blood level that kills bacteria.CTRI/2013/07/003850Tata Memorial Hospital25
已完成
3 期
Therapeutic drug monitoring-based dose optimisation of piperacillin in patients with severe sepsis or septic shock to investigate effects on organ functions and survival: a prospective, multicenter, randomized controlled trialR65.1R57.2Systemic Inflammatory Response Syndrome of infectious origin with organ failureSeptic shockDRKS00011159Friedrich-Schiller-Universität Jena254
招募中
不适用
Implementation of pharmacokinetic (PK)-guided dosing of DDAVP and VWF-containing concentrates in von Willebrand disease and low VWFVon Willebrand disease, pharmacokinetics, treatment, bleeding, surgeryNL-OMON20178Erasmus University Medical Center - Sophia Children's Hospital, University Medical Center Rotterdam123
已完成
不适用
Population Pharmacokinetic Modeling to Optimize the Dosage of the Piperacillin / Tazobactam Combination in Patients With Sepsis in Intensive CareResuscitation Patients With SepsisNCT03748095University Hospital, Rouen91
尚未招募
3 期
Determination of Correct hydroxyurea dose in Dickle Cell Anemia PatientsCTRI/2020/08/027022ICMR New Delhi